Purkinje cell protein 4 positively regulates neurite outgrowth and neurotransmitter release

Journal of Neuroscience Research

Volumn 89, Issue 10, 2011, Pages 1519-1530

  Harashima, Shin ichi ^a   Wang, Yu ^a   Horiuchi, Takahiko ^b   Seino, Yutaka ^a   Inagaki, Nobuya ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Apoptosis; Calmodulin; Neurodegenerative diseases; Neuronal cell differentiation; PCP4

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ACETYLCHOLINE; BUCLADESINE; CALMODULIN; CALMODULIN BINDING PROTEIN; DOPAMINE; DOXYCYCLINE; HYDROGEN PEROXIDE; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; NERVE GROWTH FACTOR; PURKINJE CELL PROTEIN 4; TETRACYCLINE; UNCLASSIFIED DRUG;

ALCOHOLISM; ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN; DOPAMINE RELEASE; HUNTINGTON CHOREA; NERVE FIBER GROWTH; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURKINJE CELL; RAT;

ACETYLCHOLINE; ANIMALS; CALMODULIN; CALMODULIN-BINDING PROTEINS; CELL DIFFERENTIATION; CHROMAFFIN CELLS; DOPAMINE; NERVE TISSUE PROTEINS; NEURITES; NEUROTRANSMITTER AGENTS; PC12 CELLS; RATS;

EID: 79961209848     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22688     Document Type: Article

References (34)

1. 2+, and calmodulin. Cell Signal 14: 649-654.
2. Bähler M, Rhoads A. 2002. Calmodulin signaling via the IQ motif. FEBS Lett 513: 107-113.
3. Bar-Sagi D, Feramisco JR. 1985. Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation. Cell 42: 841-848.
4. Cabin DE, Gardiner K, Reeves RH. 1996. Molecular genetic characterization and comparative mapping of the human PCP4 gene. Somat Cell Mol Genet 22: 167-175.
5. Cabin DE, McKee-Johnson JW, Matesic LE, Wiltshire T, Rue EE, Mjaatvedt AE, Huo YK, Korenberg JR, Reeves RH. 1998. Physical and comparative mapping of distal mouse chromosome 16.5 p5. Genome Res 89: 940-950.
6. Chen H, Bouras C, Antonarakis SE. 1996. Cloning of the cDNA for a human homolog of the rat PEP-19 gene and mapping to chromosome 21q22.2-q22.3. Hum Genet 98: 672-677.
7. Chen SL, Orr HT. 1990. Sequence of a murine cDNA, pcp-4, that encodes the homolog of the rat brain-specific antigen PEP-19. Nucleic Acids Res 18: 1304.
8. Dickerson JB, Morgan MA, Mishra A, Slaughter CA, Morgan JI, Zheng J. 2006. The influence of phosphorylation on the activity and structure of the neuronal IQ motif protein, PEP-19. Brain Res 1092: 16-27.
9. Erhardt JA, Legos JJ, Johanson RA, Slemmon JR, Wang X. 2000. Expression of PEP-19 inhibits apoptosis in PC12 cells. Neuroreport 11: 3719-3723.
10. 2+/calmodulin-dependent protein kinase II produce opposing effects on the affinity of calmodulin for calcium. J Biol Chem 279: 39374-39382.
11. Gerendasy DD, Sutcliffe JG. 1997. RC/neurogranin, a postsynaptic calpacitin for setting the response threshold to calcium influxes. Mol Neurobiol 15: 131-163.
12. Gui J, Song Y, Han NL, Sheu FS. 2007. Characterization of transcriptional regulation of neurogranin by nitric oxide and the role of neurogranin in SNP-induced cell death: implication of neurogranin in an increased neuronal susceptibility to oxidative stress. Int J Biol Sci 3: 212-224.
13. Hubert RS, Korenberg JR. 1997. PCP4 maps between DS21S345 and P31P10SP6 on chromosome 21q22.2→q22.3. Cytogenet Cell Genet 78: 44-45.
14. Iwamoto K, Bundo M, Yamamoto M, Ozawa H, Saito T, Kato T. 2004. Decreased expression of NEFH and PCP4/PEP19 in the prefrontal cortex of alcoholics. Neurosci Res 49: 379-385.
15. Johanson RA, Sarau HM, Foley JJ, Slemmon JR. 2000. Calmodulin-binding peptide PEP-19 modulates activation of calmodulin kinase II in situ. J Neurosci 20: 2860-2866.
16. Kirino T. 1982. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 6: 57-69.
17. Kleerekoper QK, Putkey JA. 2009. PEP-19, an intrinsically disordered regulator of calmodulin signaling. J Biol Chem 284: 7455-7464.
18. Mattson MP, Kater SB. 1989. Development and selective neurodegeneration in cell cultures from different hippocampal regions. Brain Res 490: 110-125.
19. Olson LE, Roper RJ, Baxter LL, Carlson EJ, Epstein CJ, Reeves RH. 2004. Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes. Dev Dyn 230: 581-589.
20. Putkey JA, Kleerekoper Q, Gaertner TR, Waxham MN. 2003. A new role for IQ motif proteins in regulating calmodulin function. J Biol Chem 278: 49667-49670.
21. Sangameswaran L, Hempstead J, Morgan JI. 1989. Molecular cloning of a neuron-specific transcript and its regulation during normal and aberrant cerebellar development. Proc Natl Acad Sci U S A 86: 5651-5655.
22. Shafer TJ, Atchison WD. 1991. Transmitter, ion channel and receptor properties of phenochromocytoma (PC12) cells: a model for neurotoxicological studies. Neurotoxicology 12: 473-379.
23. Simons SB, Escobedo Y, Yasuda R, Dudek SM. 2009. Regional differences in hippocampal calcium handling provide a cellular mechanism for limiting plasticity. Proc Natl Acad Sci U S A 106: 14080-14084.
24. Slemmon JR, Hughes CM, Campbell GA, Flood DG. 1994. Increased levels of hemoglobin-derived and other peptides in Alzheimer's disease cerebellum. J Neurosci 14: 2225-2235.
25. Slemmon JR, Feng B, Erhardt JA. 2000. Small proteins that modulate calmodulin-dependent signal transduction: effects of PEP-19, neuromodulin, and neurogranin on enzyme activation and cellular homeostasis. Mol Neurobiol 22: 99-113.
26. Smith DJ, Stevens ME, Sudanagunta SP, Bronson RT, Makhinson M, Watabe AM, O'Dell TJ, Fung J, Weier HU, Cheng JF, Rubin EM. 1997. Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome. Nat Genet 16: 28-36.
27. Song B, Lai B, Zheng Z, Zhang Y, Luo J, Wang C, Chen Y, Woodgett JR, Li M. 2010. Inhibitory phosphorylation of GSK-3 by CaMKII couples depolarization to neuronal survival. J Biol Chem. 285: 41122-41134.
28. Takadera T, Ohyashiki T. 2007. Calmodulin inhibitor-induced apoptosis was prevented by glycogen synthase kinase-3 inhibitors in PC12 cells. Cell Mol Neurobiol 27: 783-790.
29. Thomas S, Thiery E, Aflalo R, Vayssettes C, Verney C, Berthuy I, Créau N. 2003. PCP4 is highly expressed in ectoderm and particularly in neuroectoderm derivatives during mouse embryogenesis. Gene Express Patterns 3: 93-97.
30. Utal AK, Stopka AL, Roy M, Coleman PD. 1998. PEP-19 immunohistochemistry defines the basal ganglia and associated structures in the adult human brain, and is dramatically reduced in Huntington's disease. Neuroscience 86: 1055-1063.
31. Vaudry D, Stork PJS, Lazarovici P, Eiden LE. 2002. Signaling pathways for PC12 cell differentiation: making the right connections. Science 296: 1648-1649.
32. Xia Z, Storm DR. 2005. The role of calmodulin as a signal integrator for synaptic plasticity. Nat Rev Neurosci 6: 267-276.
33. Ziai MR, Pan YC, Hulmes JD, Sangameswaran L, Morgan JI. 1986. Isolation, sequence, and developmental profile of a brain-specific polypeptide, PEP-19. Proc Natl Acad Sci U S A 83: 8420-8423.
34. Ziai MR, Sangameswaran L, Hempstead JL, Danho W, Morgan JI. 1988. An immunochemical analysis of the distribution of a brain-specific polypeptide, PEP-19. J Neurochem 51: 1771-1776.